Since its founding in 2007, the KFBS PE Fund has made investments in 26 portfolio companies, exited 5 portfolio companies, and received 5 dividend recapitalizations. The Fund currently manages $4.4 million in assets, and holds 21 active investments, of which some are highlighted below:
Clearside Biomedical is an ophthalmic company specializing in the research, development and commercialization of therapeutic products through a proprietary ocular microinjection platform that targets the individual compartments of the eye. Currently, Clearside Biomedical is focused on its initial product candidate, CLS1001, under development for retinal applications through the delivery of proven therapeutics to the suprachoroidal space. Clearside Biomedical was founded by an executive team with extensive development and revenue growth expertise, focused on improving the delivery of therapeutic agents to improve standard of care for patients with sight threatening disease.
Clearside Biomedical, Inc., a privately held ophthalmic company developing and commercializing targeted therapeutics for the... Read more »
Surgeons at Sun Coast Bariatrics are the first in the Tampa Bay area to offer a single-incision sleeve gastrectomy procedure... Read more »